TSX/GENM (TSX/GENM)

Toronto Stock Exchange: TSX/GENM · CAD

CA$0.43

-0.01 (-2.3%)· Recorded snapshot

Market cap	300.1M
Net income (ttm)	-56M
EPS (ttm)	-CA$0.20
Shares out	697.8M
Volume	899,419
Beta	2.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -56M
EPS (ttm): -CA$0.20
Market cap: 300.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/GENM indicators

Market & fundamental data

Available fields

150

Groups with data

Currency

CAD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-08-28
Employees	13
Employees change	-4
Employees growth	-23.53%
Enterprise value	CAD 267.9M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2018
Industry	Other Industrial Metals & Mining
Is primary listing	Yes
ISIN number	CA37149B1094
Last earnings date	2025-11-14
Last refreshed	2026-10-29
Market cap	CAD 300.1M
Price	CAD 0.43
Price currency	CAD
Sector	Materials
SIC code	1000
Stock price date	2026-10-29
Symbol	tsx/GENM
Website	https://www.genmining.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-46.23%
FCF / EV yield	-5.27%
FCF yield	-4.72%
Industry forward P/E	165.41x
Sector forward P/E	15.5x
Sector P/E	22.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-51.46%
ROA (5Y)	-87.92%
ROCE	-77.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 89,102
EBIT	CAD -21.2M
EBITDA	CAD -21.1M
EPS	CAD -0.20
FCF per share	CAD -0.02
Financing cash flow	CAD 34.9M
Free cash flow	CAD -14.5M
Free cash flow minus SBC	CAD -17.4M
Gross profit	CAD -12.3M
Net borrowing	CAD -102,337
Net cash flow	CAD 20.4M
Net income	CAD -56M
Operating cash flow minus SBC	CAD -17.4M
Operating income	CAD -21.2M
Stock-based compensation	CAD 2.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.21
Interest coverage	-126.53
Long-term assets	CAD 1.2M
Long-term liabilities	CAD 94.8M
Net cash (debt)	CAD 32.2M
Net cash / market cap	10.47%
Net cash growth	171.74%
Piotroski F-Score	1
Property, plant and equipment	CAD 839,064
Shareholders' equity	CAD -67.4M
Tangible book value	CAD -67.4M
Tangible book value per share	CAD -0.21
Total assets	CAD 36.1M
Total cash	CAD 33.4M
Total debt	CAD 1.3M
Total liabilities	CAD 103.4M
WACC	15.61%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 34.9M
Current liabilities	CAD 8.6M
Current ratio	4.04
Net working capital	CAD -6M
Quick ratio	3.99
Working capital	CAD 26.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-18.75%
Shareholder yield	-18.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.63
1D price change	-2.27%
1M price change	-20%
1M total return	-20%
1W price change	-2.22%
1W total return	-2.22%
1Y price change	-11.11%
1Y return CAGR	-11.12%
1Y total return	-11.11%
20-day SMA	CAD 0.47
200-day SMA	CAD 0.65
3M price change	-25.42%
3M total return	-25.42%
3Y price change	69.23%
3Y return CAGR	19.16%
3Y total return	69.23%
50-day SMA	CAD 0.60
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.92
52-week high date	2025-12-24
52-week low	CAD 0.40
52-week low date	2026-10-22
5Y price change	-33.33%
5Y return CAGR	-7.79%
5Y total return	-33.33%
6M price change	-31.25%
6M total return	-31.25%
All-time high	CAD 1.23
All-time high date	2021-06-07
All-time low	CAD 0.08
All-time low date	2018-05-15
Average true range (ATR)	CAD 0.03
Average volume	2M
Beta (1Y)	3.24
Beta (2Y)	2.47
Beta (5Y)	2.07
Change from 52-week high	-53.26%
Change from 52-week low	7.5%
Change from all-time high	-64.23%
Change from all-time low	450%
Change from open	-1.15%
Day's gap	-1.14%
Dollar volume	CAD 386,750
High price	CAD 0.44
Low price	CAD 0.43
Monthly RSI	46.81
Open price	CAD 0.44
Position in 52-week range	0%
Previous close	CAD 0.44
Price vs 150-day SMA	-29.96%
Price vs 20-day SMA	-7.07%
Price vs 200-day SMA	-32.04%
Price vs 50-day SMA	-27.12%
Relative volume	0.45
RSI	29.63
Sharpe ratio	0.13
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	0.25
Sortino ratio	0.27
Sortino ratio (3Y)	1.03
Sortino ratio (5Y)	0.49
Volume	899.4K
Weekly RSI	34.72
YTD price change	-46.34%
YTD total return	-46.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	647M
Shares change (QoQ)	14.42%
Shares change (YoY)	18.75%
Shares held by insiders	2.58%
Shares held by institutions	20.07%
Shares outstanding	697.8M

Deeper analysis on TSX/GENM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/GENM report

Is a complete TSX/GENM research report available?

No complete published report is available for tsx/GENM (TSX/GENM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/GENM (TSX/GENM)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/GENM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/GENM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/GENM

Frequently asked questions